-
1
-
-
0036191173
-
Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
-
DOI 10.1053/jhep.2002.31250
-
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21. (Pubitemid 34183979)
-
(2002)
Hepatology
, vol.35
, Issue.3
, pp. 716-721
-
-
Ferenci, P.1
Lockwood, A.2
Mullen, K.3
Tarter, R.4
Weissenborn, K.5
Blei, A.T.6
-
2
-
-
44949122693
-
Hepatic Encephalopathy
-
DOI 10.1016/j.mcna.2008.03.009, PII S0025712508000266
-
Munoz SJ. Hepatic encephalopathy. Med Clin North Am 2008;92:795-812, viii. (Pubitemid 351822357)
-
(2008)
Medical Clinics of North America
, vol.92
, Issue.4
, pp. 795-812
-
-
Munoz, S.J.1
-
3
-
-
33846446011
-
Review article: The burden of hepatic encephalopathy
-
DOI 10.1111/j.1746-6342.2006.03215.x
-
Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(Suppl 1):3-9. (Pubitemid 46148239)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.25
, Issue.SUPPL. 1
, pp. 3-9
-
-
Poordad, F.F.1
-
5
-
-
34548136516
-
Minimal hepatic encephalopathy: A vehicle for accidents and traffic violations
-
DOI 10.1111/j.1572-0241.2007.01424.x
-
Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903-9. (Pubitemid 47301540)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.9
, pp. 1903-1909
-
-
Bajaj, J.S.1
Hafeezullah, M.2
Hoffmann, R.G.3
Saeian, K.4
-
6
-
-
39549107131
-
Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy
-
DOI 10.1002/hep.22032
-
Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG et al. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596-604. (Pubitemid 351280728)
-
(2008)
Hepatology
, vol.47
, Issue.2
, pp. 596-604
-
-
Bajaj, J.S.1
Hafeezullah, M.2
Hoffmann, R.G.3
Varma, R.R.4
Franco, J.5
Binion, D.G.6
Hammeke, T.A.7
Saeian, K.8
-
7
-
-
65449138799
-
The effect of fatigue on driving skills in patients with hepatic encephalopathy
-
Bajaj JS, Hafeezullah M, Zadvornova Y, tin E, Schubert CM, Gibson DP et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009;104:898-905.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 898-905
-
-
Bajaj, J.S.1
Hafeezullah, M.2
Zadvornova, Y.3
Tin, E.4
Schubert, C.M.5
Gibson, D.P.6
-
8
-
-
52949094627
-
Patients with minimal hepatic encephalopathy have poor insight into their driving skills
-
quiz 065
-
Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol 2008;6:1135-9; quiz 065.
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1135-1139
-
-
Bajaj, J.S.1
Saeian, K.2
Hafeezullah, M.3
Hoffmann, R.G.4
Hammeke, T.A.5
-
9
-
-
70350075400
-
Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test
-
Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009;50:1175-83.
-
(2009)
Hepatology
, vol.50
, pp. 1175-1183
-
-
Bajaj, J.S.1
Saeian, K.2
Schubert, C.M.3
Hafeezullah, M.4
Franco, J.5
Varma, R.R.6
-
10
-
-
0031834155
-
Subclinical hepatic encephalopathy impairs daily functioning
-
DOI 10.1002/hep.510280108
-
Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28:45-9. (Pubitemid 28299984)
-
(1998)
Hepatology
, vol.28
, Issue.1
, pp. 45-49
-
-
Groeneweg, M.1
Quero, J.C.2
De Bruijn, I.3
Hartmann, I.J.C.4
Essink-Bot, M.-L.5
Hop, W.C.J.6
Schalm, S.W.7
-
11
-
-
0033034892
-
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
-
DOI 10.1016/S0168-8278(99)80144-5
-
Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999;30:890-5. (Pubitemid 29248991)
-
(1999)
Journal of Hepatology
, vol.30
, Issue.5
, pp. 890-895
-
-
Bustamante, J.1
Rimola, A.2
Ventura, P.-J.3
Navasa, M.4
Cirera, I.5
Reggiardo, V.6
Rodes, J.7
-
12
-
-
20044372736
-
AASLD practice guidelines: Evaluation of the patient for liver transplantation
-
DOI 10.1002/hep.20704
-
Murray KF, Carithers RL, Jr., Aasld. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-32. (Pubitemid 40770295)
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1407-1432
-
-
Murray, K.F.1
Carithers Jr., R.L.2
-
13
-
-
84865320804
-
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009
-
Stepanova M, Mishra A, Venkatesan C, Younossi ZM. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 2012;10:1034-41 e1.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
-
-
Stepanova, M.1
Mishra, A.2
Venkatesan, C.3
Younossi, Z.M.4
-
14
-
-
33847213560
-
Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy
-
Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci 2007;52:737-41.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 737-741
-
-
Leevy, C.B.1
Phillips, J.A.2
-
15
-
-
77952744973
-
Persistence of cognitive impairment after resolution of overt hepatic encephalopathy
-
Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010;138:2332-40.
-
(2010)
Gastroenterology
, vol.138
, pp. 2332-2340
-
-
Bajaj, J.S.1
Schubert, C.M.2
Heuman, D.M.3
Wade, J.B.4
Gibson, D.P.5
Topaz, A.6
-
16
-
-
34548174883
-
Clinical manifestation, and Diagnosis of Hepatic Encephalopathy
-
D MK. Pathogenesis, Clinical manifestation, and Diagnosis of Hepatic Encephalopathy. Semin Liver Dis 2007:3-9.
-
(2007)
Semin Liver Dis
, pp. 3-9
-
-
Pathogenesis, D.M.K.1
-
17
-
-
0023277382
-
Biochemistry and physiology of brain ammonia
-
Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987;67:440-519. (Pubitemid 17063608)
-
(1987)
Physiological Reviews
, vol.67
, Issue.2
, pp. 440-519
-
-
Cooper, A.J.L.1
Plum, F.2
-
18
-
-
0343238857
-
Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema?
-
DOI 10.1016/S0168-8278(00)80110-5
-
Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000;32:1035-8. (Pubitemid 30368099)
-
(2000)
Journal of Hepatology
, vol.32
, Issue.6
, pp. 1035-1038
-
-
Haussinger, D.1
Kircheis, G.2
Fischer, R.3
Schliess, F.4
Dahl, S.V.5
-
19
-
-
0025979046
-
Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy
-
Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991;11:337-41.
-
(1991)
J Cereb Blood Flow Metab
, vol.11
, pp. 337-341
-
-
Lockwood, A.H.1
Yap, E.W.2
Wong, W.H.3
-
20
-
-
33745548101
-
Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis
-
DOI 10.1002/hep.21235
-
Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1187-90. (Pubitemid 43980095)
-
(2006)
Hepatology
, vol.43
, Issue.6
, pp. 1187-1190
-
-
Haussinger, D.1
-
22
-
-
0025292201
-
"Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy
-
14
-
Mullen KD, Szauter KM, Kaminsky-Russ K. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 1990 14;336(8707):81-3.
-
(1990)
Lancet
, vol.336
, Issue.8707
, pp. 81-83
-
-
Mullen, K.D.1
Szauter, K.M.2
Kaminsky-Russ, K.3
-
24
-
-
77957345947
-
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy
-
Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010;53:849-55.
-
(2010)
J Hepatol
, vol.53
, pp. 849-855
-
-
Gupta, A.1
Dhiman, R.K.2
Kumari, S.3
Rana, S.4
Agarwal, R.5
Duseja, A.6
-
25
-
-
77953638458
-
Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients
-
Jun DW, Kim KT, Lee OY, Chae JD, Son BK, Kim SH et al. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci 2010;55:1465-71.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 1465-1471
-
-
Jun, D.W.1
Kim, K.T.2
Lee, O.Y.3
Chae, J.D.4
Son, B.K.5
Kim, S.H.6
-
26
-
-
84856407574
-
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients withompensated cirrhosis
-
Kalambokis GN, Tsianos EV. Rifaximin reduces endotoxemia and improves liver function and disease severity in patients withompensated cirrhosis. Hepatology 2012;55:655-6.
-
(2012)
Hepatology
, vol.55
, pp. 655-656
-
-
Kalambokis, G.N.1
Tsianos, E.V.2
-
27
-
-
0026691627
-
Serum levels of cytokines in chronic liver diseases
-
Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
-
(1992)
Gastroenterology
, vol.103
, pp. 264-274
-
-
Tilg, H.1
Wilmer, A.2
Vogel, W.3
Herold, M.4
Nolchen, B.5
Judmaier, G.6
-
28
-
-
84875670330
-
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
-
Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One 2013;8:e60042.
-
(2013)
PLoS One
, vol.8
-
-
Bajaj, J.S.1
Heuman, D.M.2
Sanyal, A.J.3
Hylemon, P.B.4
Sterling, R.K.5
Stravitz, R.T.6
-
29
-
-
84866396844
-
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
-
Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012;303:G675-85.
-
(2012)
Am J Physiol Gastrointest Liver Physiol
, vol.303
-
-
Bajaj, J.S.1
Hylemon, P.B.2
Ridlon, J.M.3
Heuman, D.M.4
Daita, K.5
White, M.B.6
-
30
-
-
79953765823
-
Hepatic encephalopathy: A central neuroinflammatory disorder?
-
Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011;53:1372-6.
-
(2011)
Hepatology
, vol.53
, pp. 1372-1376
-
-
Butterworth, R.F.1
-
31
-
-
79960714764
-
Characterization of fecal microbial communities in patients with liver cirrhosis
-
Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011;54:562-72.
-
(2011)
Hepatology
, vol.54
, pp. 562-572
-
-
Chen, Y.1
Yang, F.2
Lu, H.3
Wang, B.4
Chen, Y.5
Lei, D.6
-
32
-
-
84884357277
-
Overt hepatic encephalopathy in cirrhosis: Influence of multiple clinical precipitants resulting in hospitalization
-
abstract
-
Pantham G, Waghray N, Prakash R, Biyyani RS, Mullen KD. Overt hepatic encephalopathy in cirrhosis: influence of multiple clinical precipitants resulting in hospitalization. Gastroenterology 2012;142(Suppl 1):S950 (abstract).
-
(2012)
Gastroenterology
, vol.142
, Issue.SUPPL. 1
-
-
Pantham, G.1
Waghray, N.2
Prakash, R.3
Biyyani, R.S.4
Mullen, K.D.5
-
33
-
-
79955753653
-
Current concepts in the pathophysiology and management of hepatic encephalopathy
-
N Y
-
Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y) 2011;7:222-33.
-
(2011)
Gastroenterol Hepatol
, vol.7
, pp. 222-233
-
-
Frederick, R.T.1
-
34
-
-
14644389447
-
Endoscopic coagulation therapy is successful for improving encephalopathy in cirrhotic patients with gastric antral vascular ectasia
-
Zushi S IY, Fukuda K et al. Endoscopic coagulation therapy is successful for improving encephalopathy in cirrhotic patients with gastric antral vascular ectasia. Digestive Endoscopy 2005;32-5.
-
(2005)
Digestive Endoscopy
, pp. 32-35
-
-
Zushi, S.I.Y.1
Fukuda, K.2
-
35
-
-
0034944406
-
Practice Parameters Committee of the American College of G. Hepatic Encephalopathy
-
Blei AT, Cordoba J, Practice Parameters Committee of the American College of G. Hepatic Encephalopathy. Am J Gastroenterol 2001;96:1968-76.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 1968-1976
-
-
Blei, A.T.1
Cordoba, J.2
-
36
-
-
34548185116
-
An algorithm for the management of hepatic encephalopathy
-
Prakash RK, Kanna S, Mullen KD. An algorithm for the management of hepatic encephalopathy. Semin Liver Dis 2007;27(Suppl 2):32-48.
-
(2007)
Semin Liver Dis
, vol.27
, Issue.SUPPL. 2
, pp. 32-48
-
-
Prakash, R.K.1
Kanna, S.2
Mullen, K.D.3
-
37
-
-
33947387582
-
Can we ignore minimal hepatic encephalopathy any longer?
-
DOI 10.1002/hep.21617
-
Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 2007;45:547-8. (Pubitemid 46450606)
-
(2007)
Hepatology
, vol.45
, Issue.3
, pp. 547-548
-
-
Qadri, A.M.1
Ogunwale, B.O.2
Mullen, K.D.3
-
38
-
-
77950586321
-
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients
-
Bajaj JS, Sanyal AJ, Bell D, Gilles H, Heuman DM. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther 2010;31:1012-7.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 1012-1017
-
-
Bajaj, J.S.1
Sanyal, A.J.2
Bell, D.3
Gilles, H.4
Heuman, D.M.5
-
40
-
-
69249166158
-
Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo
-
Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009;137:885-91, 91 e1.
-
(2009)
Gastroenterology
, vol.137
-
-
Sharma, B.C.1
Sharma, P.2
Agrawal, A.3
Sarin, S.K.4
-
41
-
-
84864296945
-
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose
-
Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol 2012;27:1329-35.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 1329-1335
-
-
Sharma, P.1
Sharma, B.C.2
Agrawal, A.3
Sarin, S.K.4
-
42
-
-
43449114798
-
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy
-
DOI 10.1097/MEG.0b013e3282f3e6f5, PII 0004273720080600000007
-
Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008;20:506-11. (Pubitemid 351667890)
-
(2008)
European Journal of Gastroenterology and Hepatology
, vol.20
, Issue.6
, pp. 506-511
-
-
Sharma, P.1
Sharma, B.C.2
Puri, V.3
Sarin, S.K.4
-
43
-
-
84863722812
-
Secondary prophylaxis of hepatic encephalopathy in cirrhosis: An open-label, randomized controlled trial of lactulose, probiotics, and no therapy
-
Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 2012;107:1043-50.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1043-1050
-
-
Agrawal, A.1
Sharma, B.C.2
Sharma, P.3
Sarin, S.K.4
-
44
-
-
33947392621
-
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
-
DOI 10.1002/hep.21533
-
Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007;45:549-59. (Pubitemid 46450607)
-
(2007)
Hepatology
, vol.45
, Issue.3
, pp. 549-559
-
-
Prasad, S.1
Dhiman, R.K.2
Duseja, A.3
Chawla, Y.K.4
Sharma, A.5
Agarwal, R.6
-
45
-
-
79951678831
-
Meta-analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy
-
Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011;33:662-71.
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 662-671
-
-
Shukla, S.1
Shukla, A.2
Mehboob, S.3
Guha, S.4
-
46
-
-
80955157383
-
Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: A meta-analysis
-
Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 2011;23:1250-7.
-
(2011)
Eur J Gastroenterol Hepatol
, vol.23
, pp. 1250-1257
-
-
Luo, M.1
Li, L.2
Lu, C.Z.3
Cao, W.K.4
-
47
-
-
0024383446
-
Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt
-
DOI 10.1007/BF01540265
-
Riggio O, Balducci G, Ariosto F, Merli M, Pieche U, Pinto G et al. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig Dis Sci 1989;34:823-9. (Pubitemid 19157836)
-
(1989)
Digestive Diseases and Sciences
, vol.34
, Issue.6
, pp. 823-829
-
-
Riggio, O.1
Balducci, G.2
Ariosto, F.3
Merli, M.4
Pieche, U.5
Pinto, G.6
Tremiterra, S.7
Ziparo, V.8
Capocaccia, L.9
-
48
-
-
0023552427
-
Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: A double-blind, randomized trial
-
DOI 10.1002/hep.1840070617
-
Morgan MY, Hawley KE. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology 1987;7:1278-84. (Pubitemid 18014202)
-
(1987)
Hepatology
, vol.7
, Issue.6
, pp. 1278-1284
-
-
Morgan, M.Y.1
Hawley, K.E.2
-
49
-
-
0023772137
-
Lactitol vs. Lactulose in the treatment of chronic recurrent portalsystemic encephalopathy
-
Heredia D, Teres J, Orteu N, Rodes J. Lactitol vs. lactulose in the treatment of chronic recurrent portalsystemic encephalopathy. J Hepatol 1988;7:106-10.
-
(1988)
J Hepatol
, vol.7
, pp. 106-110
-
-
Heredia, D.1
Teres, J.2
Orteu, N.3
Rodes, J.4
-
50
-
-
84862664992
-
Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites
-
Kalambokis GN, Mouzaki A, Rodi M, Pappas K, Fotopoulos A, Xourgia X et al. Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin Gastroenterol Hepatol 2012;10:815-8.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 815-818
-
-
Kalambokis, G.N.1
Mouzaki, A.2
Rodi, M.3
Pappas, K.4
Fotopoulos, A.5
Xourgia, X.6
-
51
-
-
84899697590
-
Rifaximinreases venous ammonia concentrations and time-weighted average ammonia concentrations correlate with overt hepatic encephalopathy as assessed by conn score with overt hepatic encephalopathy
-
Sanyal A BN, Poordad F, Sheikh M, Mullen K, Sigal S, Frederick T. Rifaximinreases venous ammonia concentrations and time-weighted average ammonia concentrations correlate with overt hepatic encephalopathy as assessed by conn score with overt hepatic encephalopathy. Program and Abstracts of the 45th Annual Meeting of European Association for the Study of the Liver Abstract 195 2010.
-
Program and Abstracts of the 45th Annual Meeting of European Association for the Study of the Liver Abstract 195 2010
-
-
Sanyal, A.B.N.1
Poordad, F.2
Sheikh, M.3
Mullen, K.4
Sigal, S.5
Frederick, T.6
-
52
-
-
85044701545
-
Neomycin in the treatment of hepatic coma
-
21
-
Dawson AM, Mc LJ, Sherlock S. Neomycin in the treatment of hepatic coma. Lancet 1957 21;273:1262-8.
-
(1957)
Lancet
, vol.273
, pp. 1262-1268
-
-
Dawson, A.M.1
Mc, L.J.2
Sherlock, S.3
-
53
-
-
0017744177
-
Comparison of lactulose and neomycin in the treatment of chronic portal systemic encephalopathy. A double blind controlled trial
-
Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72(4 Pt 1):573-83. (Pubitemid 8097592)
-
(1977)
Gastroenterology
, vol.72
, Issue.41
, pp. 573-583
-
-
Conn, H.O.1
Leevy, C.M.2
Vlahcevic, Z.R.3
-
54
-
-
0030868006
-
Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial
-
Miglio F, Valpiani D, Rossellini SR, Ferrieri A. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial. Curr Med Res Opin 1997;13:593-601. (Pubitemid 27404093)
-
(1997)
Current Medical Research and Opinion
, vol.13
, Issue.10
, pp. 593-601
-
-
Miglio, F.1
Valpiani, D.2
Rossellini, S.R.3
Ferrieri, A.4
Canova, N.5
-
55
-
-
84899697830
-
-
Salix Pharmaceuticals, Inc, Morrisville, NC, USA
-
Pharmaceuticals S. Xifanxan, package insert. Salix Pharmaceuticals, Inc, Morrisville, NC, USA; 2010.
-
(2010)
Xifanxan, Package Insert
-
-
Pharmaceuticals, S.1
-
56
-
-
0028041535
-
Pharmacokinetic study of rifaximin after oral administration in healthy volunteers
-
Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int J Clin Pharmacol Res 1994;14:51-6. (Pubitemid 24289441)
-
(1994)
International Journal of Clinical Pharmacology Research
, vol.14
, Issue.2
, pp. 51-56
-
-
Descombe, J.J.1
Dubourg, D.2
Picard, M.3
Palazzani, E.4
-
57
-
-
18644365788
-
Rifaximin: In vitro and in vivo antibacterial activity - A review
-
DOI 10.1159/000081991
-
Jiang ZD, DuPont HL. Rifaximin: in vitro and in vivo antibacterial activity - a review. Chemotherapy 2005;51(Suppl 1):67-72. (Pubitemid 40663191)
-
(2005)
Chemotherapy
, vol.51
, Issue.SUPPL. 1
, pp. 67-72
-
-
Jiang, Z.D.1
Dupont, H.L.2
-
58
-
-
0035986441
-
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis
-
Brigidi P, Swennen E, Rizzello F, Bozzolasco M, Matteuzzi D. Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis. J Chemother 2002;14:290-5. (Pubitemid 34734574)
-
(2002)
Journal of Chemotherapy
, vol.14
, Issue.3
, pp. 290-295
-
-
Brigidi, P.1
Swennen, E.2
Rizzello, F.3
Bozzolasco, M.4
Matteuzzi, D.5
-
59
-
-
79251535022
-
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy
-
Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011;140:478-87 e1.
-
(2011)
Gastroenterology
, vol.140
-
-
Bajaj, J.S.1
Heuman, D.M.2
Wade, J.B.3
Gibson, D.P.4
Saeian, K.5
Wegelin, J.A.6
-
60
-
-
77950246404
-
Rifaximin treatment in hepatic encephalopathy
-
25
-
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010 25;362:1071-81.
-
(2010)
N Engl J Med
, vol.362
, pp. 1071-1081
-
-
Bass, N.M.1
Mullen, K.D.2
Sanyal, A.3
Poordad, F.4
Neff, G.5
Leevy, C.B.6
-
61
-
-
84878018203
-
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: What is the evidence?
-
Gluud LL, Dam G, Borre M, Les I, Cordoba J,chesini G et al. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? Metab Brain Dis 2013;28:221-5.
-
(2013)
Metab Brain Dis
, vol.28
, pp. 221-225
-
-
Gluud, L.L.1
Dam, G.2
Borre, M.3
Les, I.4
Cordoba, J.5
Chesini, G.6
-
62
-
-
84855778186
-
Durability of rifaximin response in hepatic encephalopathy
-
Neff GW, Jones M, Broda T, Jonas M, Ravi R,ick D et al. Durability of rifaximin response in hepatic encephalopathy. J Clin Gastroenterol 2012;46:168-71.
-
(2012)
J Clin Gastroenterol
, vol.46
, pp. 168-171
-
-
Neff, G.W.1
Jones, M.2
Broda, T.3
Jonas, M.4
Ravi, R.5
Ick, D.6
-
63
-
-
79751499077
-
Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial)
-
Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011;106:307-16.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 307-316
-
-
Sidhu, S.S.1
Goyal, O.2
Mishra, B.P.3
Sood, A.4
Chhina, R.S.5
Soni, R.K.6
-
64
-
-
0037232911
-
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: Results of a randomized, double-blind, double-dummy, controlled clinical trial
-
DOI 10.1016/S0168-8278(02)00350-1, PII S0168827802003501
-
Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol 2003;38:51-8. (Pubitemid 36078524)
-
(2003)
Journal of Hepatology
, vol.38
, Issue.1
, pp. 51-58
-
-
Mas, A.1
Rodes, J.2
Sunyer, L.3
Rodrigo, L.4
Planas, R.5
Vargas, V.6
Castells, L.7
Rodriguez-Martinez, D.8
Fernandez-Rodriguez, C.9
Coll, I.10
Pardo, A.11
-
65
-
-
55349090301
-
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: A meta-analysis
-
Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 2008;20:1064-70.
-
(2008)
Eur J Gastroenterol Hepatol
, vol.20
, pp. 1064-1070
-
-
Jiang, Q.1
Jiang, X.H.2
Zheng, M.H.3
Jiang, L.M.4
Chen, Y.P.5
Wang, L.6
-
66
-
-
84857577254
-
Rifaximin vs. Conventional oral therapy for hepatic encephalopathy: A meta-analysis
-
Eltawil KM, Laryea M, Peltekian K, Molinari M. Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis. World J Gastroenterol 2012;18:767-77.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 767-777
-
-
Eltawil, K.M.1
Laryea, M.2
Peltekian, K.3
Molinari, M.4
-
67
-
-
84904384671
-
Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy
-
Epub ahead of print
-
Mullen KD, Sanyal AJ, Bass NM, Poordad FF, Sheikh MY, Frederick RT et al. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2013 [Epub ahead of print].
-
(2013)
Clin Gastroenterol Hepatol
-
-
Mullen, K.D.1
Sanyal, A.J.2
Bass, N.M.3
Poordad, F.F.4
Sheikh, M.Y.5
Frederick, R.T.6
-
68
-
-
84883744232
-
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy
-
Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol 2013;108:1458-63.
-
(2013)
Am J Gastroenterol
, vol.108
, pp. 1458-1463
-
-
Sharma, B.C.1
Sharma, P.2
Lunia, M.K.3
Srivastava, S.4
Goyal, R.5
Sarin, S.K.6
-
70
-
-
50649088399
-
Probiotic yogurt for the treatment of minimal hepatic encephalopathy
-
Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008;103:1707-15.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1707-1715
-
-
Bajaj, J.S.1
Saeian, K.2
Christensen, K.M.3
Hafeezullah, M.4
Varma, R.R.5
Franco, J.6
-
71
-
-
2342580955
-
Synbiotic Modulation of Gut Flora: Effect on Minimal Hepatic Encephalopathy in Patients with Cirrhosis
-
DOI 10.1002/hep.20194
-
Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441-9. (Pubitemid 38569067)
-
(2004)
Hepatology
, vol.39
, Issue.5
, pp. 1441-1449
-
-
Liu, Q.1
Duan, Z.P.2
Ha, D.K.3
Bengmark, S.4
Kurtovic, J.5
Riordan, S.M.6
-
72
-
-
34848832109
-
Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled study
-
DOI 10.1007/s10620-006-9687-y
-
Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52:3259-65. (Pubitemid 47512537)
-
(2007)
Digestive Diseases and Sciences
, vol.52
, Issue.11
, pp. 3259-3265
-
-
Malaguarnera, M.1
Greco, F.2
Barone, G.3
Gargante, M.P.4
Malaguarnera, M.5
Toscano, M.A.6
-
73
-
-
84865420970
-
Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy
-
Holte K, Krag A, Gluud LL. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatol Res 2012;42:1008-15.
-
(2012)
Hepatol Res
, vol.42
, pp. 1008-1015
-
-
Holte, K.1
Krag, A.2
Gluud, L.L.3
-
75
-
-
80155209767
-
A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy
-
Saji S, Kumar S, Thomas V. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy. Trop Gastroenterol 2011;32:128-32.
-
(2011)
Trop Gastroenterol
, vol.32
, pp. 128-132
-
-
Saji, S.1
Kumar, S.2
Thomas, V.3
-
76
-
-
0025231570
-
Nitrogen metabolism in liver: Structural and functional organization and physiological relevance
-
15
-
Haussinger D. Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J 1990 15;267:281-90
-
(1990)
Biochem J
, vol.267
, pp. 281-290
-
-
Haussinger, D.1
-
77
-
-
57549087927
-
L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy
-
Ahmad I, Khan AA, Alam A, Dilshad A, Butt AK, Shafqat F et al. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J Coll Physicians Surg Pak 2008;18:684-7.
-
(2008)
J Coll Physicians Surg Pak
, vol.18
, pp. 684-687
-
-
Ahmad, I.1
Khan, A.A.2
Alam, A.3
Dilshad, A.4
Butt, A.K.5
Shafqat, F.6
-
78
-
-
84856048480
-
Efficacy of L-omithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy
-
Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA et al. Efficacy of L-omithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. J Coll Physicians Surg Pak 2011;21:666-71.
-
(2011)
J Coll Physicians Surg Pak
, vol.21
, pp. 666-671
-
-
Abid, S.1
Jafri, W.2
Mumtaz, K.3
Islam, M.4
Abbas, Z.5
Shah, H.A.6
-
79
-
-
84876982943
-
1-ornithine-1-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials
-
Bai M, Yang Z, Qi X, Fan D, Han G. 1-ornithine-1-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2013;28:783-92.
-
(2013)
J Gastroenterol Hepatol
, vol.28
, pp. 783-792
-
-
Bai, M.1
Yang, Z.2
Qi, X.3
Fan, D.4
Han, G.5
-
80
-
-
79959499072
-
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition
-
Ndraha S, Hasan I, Simadibrata M. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Med Indones 2011;43:18-22.
-
(2011)
Acta Med Indones
, vol.43
, pp. 18-22
-
-
Ndraha, S.1
Hasan, I.2
Simadibrata, M.3
-
81
-
-
84907877160
-
Oral 1-ornithine-1-aspartate in minimal hepatic encephalopathy: A randomized, double blind placebo-controlled trial
-
Epub ahead of print
-
Alvares-da-Silva MR, de Araujo A, Vicenzi JR, da Silva GV, Oliveira FB, Schacher F et al. Oral 1-ornithine-1-aspartate in minimal hepatic encephalopathy: a randomized, double blind placebo-controlled trial. Hepatol Res 2013 [Epub ahead of print].
-
(2013)
Hepatol Res
-
-
Alvares-da-Silva, M.R.1
De Araujo, A.2
Vicenzi, J.R.3
Da Silva, G.V.4
Oliveira, F.B.5
Schacher, F.6
-
82
-
-
77950614259
-
A double-blind, randomized, placebo-controlled trial of intravenous L-omithine-L-aspartate on postural control in patients with cirrhosis
-
Schmid M, Peck-Radosavljevic M, Konig F, Mittermaier C, Gangl A, Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-omithine-L-aspartate on postural control in patients with cirrhosis. Liver Int 2010;30:574-82.
-
(2010)
Liver Int
, vol.30
, pp. 574-582
-
-
Schmid, M.1
Peck-Radosavljevic, M.2
Konig, F.3
Mittermaier, C.4
Gangl, A.5
Ferenci, P.6
-
83
-
-
0015218210
-
False neurotransmitters and hepatic failure
-
10
-
Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971 10;2:75-80.
-
(1971)
Lancet
, vol.2
, pp. 75-80
-
-
Fischer, J.E.1
Baldessarini, R.J.2
-
84
-
-
79951683404
-
Diet and cognition in chronic liver disease
-
Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr Opin Gastroenterol 2011;27:174-9.
-
(2011)
Curr Opin Gastroenterol
, vol.27
, pp. 174-179
-
-
Kachaamy, T.1
Bajaj, J.S.2
-
85
-
-
84881361645
-
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials
-
Gluud LL, Dam G, Borre M, Les I, Cordoba J,chesini G et al. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials. J Nutr 2013;143:1263-8.
-
(2013)
J Nutr
, vol.143
, pp. 1263-1268
-
-
Gluud, L.L.1
Dam, G.2
Borre, M.3
Les, I.4
Cordoba, J.5
Chesini, G.6
-
86
-
-
33744531821
-
ESPEN Guidelines on Enteral Nutrition: Liver disease
-
DOI 10.1016/j.clnu.2006.01.018, PII S0261561406000380
-
Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006;25:285-94. (Pubitemid 43811683)
-
(2006)
Clinical Nutrition
, vol.25
, Issue.2
, pp. 285-294
-
-
Plauth, M.1
Cabre, E.2
Riggio, O.3
Assis-Camilo, M.4
Pirlich, M.5
Kondrup, J.6
Ferenci, P.7
Holm, E.8
Vom, D.S.9
Muller, M.J.10
Nolte, W.11
-
87
-
-
13544253737
-
A randomized controlled trial of acarbose in hepatic encephalopathy
-
DOI 10.1016/S1542-3565(04)00667-6, PII 1010531542356504006676
-
Gentile S, Guarino G, Romano M, Alagia IA, Fierro M, Annunziata S et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005;3:184-91. (Pubitemid 40220314)
-
(2005)
Clinical Gastroenterology and Hepatology
, vol.3
, Issue.2
, pp. 184-191
-
-
Gentile, S.1
Guarino, G.2
Romano, M.3
Alagia, I.A.4
Fierro, M.5
Annunziata, S.6
Magliano, P.L.7
Gravina, A.G.8
Torella, R.9
-
88
-
-
0026661330
-
Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial
-
Sushma S, Dasarathy S, Tandon RK, Jain S, Gupta S, Bhist MS. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 1992;16:138-44.
-
(1992)
Hepatology
, vol.16
, pp. 138-144
-
-
Sushma, S.1
Dasarathy, S.2
Tandon, R.K.3
Jain, S.4
Gupta, S.5
Bhist, M.S.6
-
90
-
-
0025768460
-
Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial
-
Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991;36:1204-8.
-
(1991)
Dig Dis Sci
, vol.36
, pp. 1204-1208
-
-
Riggio, O.1
Ariosto, F.2
Merli, M.3
Caschera, M.4
Zullo, A.5
Balducci, G.6
-
91
-
-
67949085071
-
Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy
-
Fichet J, Mercier E, Genee O, Garot D, Legras A, Dequin PF et al. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care 2009;24:364-70.
-
(2009)
J Crit Care
, vol.24
, pp. 364-370
-
-
Fichet, J.1
Mercier, E.2
Genee, O.3
Garot, D.4
Legras, A.5
Dequin, P.F.6
-
92
-
-
78649663017
-
Incomplete Reversal of Cognitive Dysfunction After Liver Transplantation in Individuals Who Had Overt Hepatic Encephalopathy Before Liver Transplantation
-
Campagna F BA, Montagnese S et al. Incomplete Reversal of Cognitive Dysfunction After Liver Transplantation in Individuals Who Had Overt Hepatic Encephalopathy Before Liver Transplantation. J Hepatol 2010 (52 [Suppl]):S187.
-
(2010)
J Hepatol
, Issue.52 SUPPL.
-
-
Campagna, F.1
B, A.2
Montagnese, S.3
-
93
-
-
78751682795
-
Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy
-
Riggio O, Ridola L, Pasquale C, Nardelli S, Pentassuglio I, Moscucci F et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011;9:181-3.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 181-183
-
-
Riggio, O.1
Ridola, L.2
Pasquale, C.3
Nardelli, S.4
Pentassuglio, I.5
Moscucci, F.6
-
94
-
-
61549097213
-
Management options for minimal hepatic encephalopathy
-
Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2008;2:785-90.
-
(2008)
Expert Rev Gastroenterol Hepatol
, vol.2
, pp. 785-790
-
-
Bajaj, J.S.1
-
95
-
-
0042470872
-
Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
-
Quero Guillen JC, Groeneweg M, Jimenez Saenz M, Schalm SW, Herrerias Gutierrez JM. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy? Rev Esp Enferm Dig 2002;94:544-57.
-
(2002)
Rev Esp Enferm Dig
, vol.94
, pp. 544-557
-
-
Quero Guillen, J.C.1
Groeneweg, M.2
Jimenez Saenz, M.3
Schalm, S.W.4
Herrerias Gutierrez, J.M.5
-
96
-
-
75749105423
-
Review article: The modern management of hepatic encephalopathy
-
Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 2010;31:537-47.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 537-547
-
-
Bajaj, J.S.1
|